Noto
- Company typePrivate
- Founded2014
- HeadquartersChicago, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
Noto firmographics
Firmographics- Name
- Noto
- Legal name
- Noto.ai, Inc.
- Website
- https://noto.ai
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Noto industry classification
Industry- Product category
- Specialty Behavioral Health Platform
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420), Outpatient Mental Health and Substance Abuse Centers (62142)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Psychiatry & Medication Management Platforms (HLALAEAB)
Keywords
Where Noto is headquartered
LocationHeadquarters
- HQ city
- Chicago
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Noto business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Insurance reimbursement / B2B payer contracts: Noto specialty therapy brands partner with health insurers (BlueCross BlueShield, Cigna, Kaiser Permanente, Aetna) covering 70+ payers nationally to serve their members with complex conditions. Services are billed through insurance, with Noto managing full-time specialty therapy networks on behalf of payer partners.
- Value-based care savings: NOCD achieved $3,430 per member per year savings compared to standard care ($925 vs $4,355 annual cost increase per member). Analysis conducted with Optum in 2025. This suggests value-based contracting with payers based on cost savings and clinical outcomes.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Noto product offering
Product offeringCore offering
Noto operates an AI-enabled platform that builds, scales, and manages specialty therapy brands for complex psychiatric and behavioral conditions. The platform partners with health insurers to identify and enroll members, deploys AI agents across care operations, and operates full-time specialty therapist networks delivering evidence-based treatments such as ERP therapy. Specialty therapy brands under the Noto umbrella include NOCD for OCD and related conditions and Rebound for trauma disorders.
Product overview
Noto is an AI-enabled platform that transforms specialty therapy to end the mental health crisis. The platform operates a multi-brand portfolio model where each specialty condition (OCD, trauma, panic, eating disorders) has its own branded therapy offering, all powered by shared Noto infrastructure. The core Noto AI Platform enables partner integration with 70+ national payers, AI-powered member identification campaigns, community engagement for enrollment, and management of full-time specialty therapist networks. NOCD (treatmyocd.com) is Noto's first and flagship specialty brand serving OCD and related disorders at scale, followed by Rebound for trauma disorders. Additional specialties for panic disorder and eating disorders are in development.
Differentiator
Problem solved
Functional benefit
Products and services
- Noto AI Platform AI-enabled infrastructure platform that powers Noto's specialty therapy brands by enabling payer partnerships, AI-powered member identification and enrollment campaigns, community engagement, and management of full-time specialty therapist networks and care teams.
- NOCD Noto's first specialty therapy brand focused on OCD and related conditions; provides full-stack OCD treatment including ERP therapy, clinical training, and continuing education, and is the leader in serving the OCD population at scale.
- Rebound Noto specialty therapy brand focused on trauma disorders, including PTSD and related conditions; currently in commercialization phase leveraging the infrastructure built from scaling NOCD.
- Panic Disorder Specialty Specialty therapy brand in development for panic disorder, currently in protocol validation phase.
- Eating Disorders Specialty Specialty therapy brand in development for eating disorders, currently in early development stages.
Quantifiable outcome
- 138 million lives covered by payers (up from <1 million)
- +6 more outcomes
Companies that use Noto
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Noto technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Noto partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- BlueCross BlueShieldcoreMajor health insurance provider partnering with Noto to serve their members with complex psychiatric conditions through Noto's specialty therapy brands and platform capabilities.
- CignacoreMajor health insurance provider partnering with Noto to serve their members with complex psychiatric conditions through Noto's specialty therapy brands and platform capabilities.
- Kaiser PermanentecoreMajor integrated health system partnering with Noto to serve their members with complex psychiatric conditions through Noto's specialty therapy brands and platform capabilities.
- AetnacoreMajor health insurance provider partnering with Noto to serve their members with complex psychiatric conditions through Noto's specialty therapy brands and platform capabilities.
- NOCDcoreNoto's first specialty therapy brand and the leader in serving OCD and related conditions. NOCD was the proof of concept for Noto's platform model, demonstrating dramatic improvements in payer coverage, wait times, outcomes, and costs. The entire OCD treatment journey from identification to maintenance therapy is owned by NOCD and enabled by Noto.
- ReboundcoreNoto specialty therapy brand focused on trauma disorders (7.0% prevalence). Currently in the commercialization phase, leveraging the infrastructure built from scaling NOCD.
- OptumminorHealthcare analytics company that collaborated on a 2025 study demonstrating $3,430 per member per year savings achieved by NOCD compared to standard care ($925 vs $4,355 annual cost increase per member).
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
Noto competitors and assessment
Company assessmentDirect peers
- Two Chairs: Two Chairs is a therapy provider that partners with payers and employers to deliver in-network outpatient behavioral health. It shares Noto's payer-contracted specialty therapy model and B2B2C distribution approach.
- Sondermind: Sondermind operates a hybrid in-person and virtual therapy network contracted with insurers to deliver outpatient mental health services. It is a direct peer on payer-contracted specialty therapy infrastructure.
- Spring Health: Spring Health provides mental health benefits to employers and health plans with a precision-matching model across therapy, coaching, and medication. Like Noto, it sells specialty care into payer contracts at scale and competes for similar B2B2C relationships.
- Cerebral: Cerebral is a virtual mental health platform focused on therapy and medication management for anxiety, depression, and ADHD, with payer and direct-pay channels. It overlaps with Noto in payer-partnered behavioral health delivery, though with more emphasis on medication management.
- Brightside Health: Brightside Health is a telehealth platform focused on anxiety and depression treatment combining therapy and medication, sold to payers and employers. It is comparable to Noto in delivering specialty psychiatric care via payer contracts.
- Talkspace: Talkspace is a publicly traded online therapy platform that contracts with insurers and employers to deliver behavioral health services. It is a direct peer on the virtual therapy / payer partnership axis where Noto competes.
- Lyra Health: Lyra Health is a B2B2C mental health benefits platform that partners with employers and payers to deliver therapy and coaching services. It is the closest direct competitor to Noto, operating a similar payer-contracted specialty therapy model.
- Headspace Health: Headspace Health (formed by the Ginger + Headspace merger) is a digital mental health platform serving employers, payers, and consumers with therapy, coaching, and self-care. It competes with Noto for payer relationships and member mindshare.
Broad incumbents
- Magellan Health: Magellan Health is a managed behavioral health care organization serving health plans and employers at scale. It is a broad incumbent peer, with Noto's CRO having previously led payer relations there.
- Optum Behavioral Health: Optum (UnitedHealth Group) operates the largest US behavioral health network and payer-aligned care delivery platform. It is a broad incumbent that competes with Noto in payer contracting and validated NOCD savings via its 2025 study.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Noto social profiles
Digital presenceNoto compliance and trust
Trust signalCompliance2 records
Noto financial estimates
Financial estimateRevenue estimate
Valuation estimate
Noto leadership team
Management profileNumber of profiles
Profiles11 records
Noto subsidiaries and ownership
Company hierarchySubsidiaries2 records
Noto funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Noto M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Noto
What does Noto do?
Noto operates an AI-enabled platform that builds, scales, and manages specialty therapy brands for complex psychiatric and behavioral conditions. The platform partners with health insurers to identify and enroll members, deploys AI agents across care operations, and operates full-time specialty therapist networks delivering evidence-based treatments such as ERP therapy. Specialty therapy brands under the Noto umbrella include NOCD for OCD and related conditions and Rebound for trauma disorders.
Is Noto a public or private company?
Noto is a private company. It is classified as venture growth investor backed and is currently operating.
When was Noto founded?
Noto was founded in 2014. It employs 101 to 250 people.
Where is Noto based?
Noto is headquartered in Chicago, United States, in the North America region.
How does Noto make money?
Two revenue lines are on record. Insurance reimbursement / B2B payer contracts are the primary driver. The others are value-based care savings.
Who are Noto's main competitors?
Direct peers on record are Two Chairs, Sondermind, Spring Health, Cerebral, Brightside Health, Talkspace, Lyra Health and Headspace Health. Broad incumbents are Magellan Health and Optum Behavioral Health.
Does Noto have an API?
No public API is recorded for Noto.
What industry is Noto in?
Noto's product category is Specialty Behavioral Health Platform. Its primary akta.pro industry code is HLALAEAB, Psychiatry & Medication Management Platforms. Its NAICS code is 621420 and its SIC code is 8093.